Related Experiment Video
Updated: Aug 30, 2025

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
Chryseobacterium indologenes Ventilator-Associated Pneumonia in an Elderly Patient: A Case Report
Mahdi M Fadlallah1,2, Darine M Kharroubi1,2, Zeinab Zeineddine1,2
1Department of Laboratory Medicine, Al-Zahraa Hospital University Medical Center, Beirut, LBN.
Abstract:
Chryseobacterium indologenes is a rare non-fermenting gram-negative pathogen that can cause opportunistic infections in humans. Most infections are nosocomial and acquired through contaminated devices such as ventilators, endotracheal tubes, and indwelling catheters. An increasing number of infections have been reported in recent years after the first reported case of ventilator-associated pneumonia in 1993. Blood, lung, ocular, and peritoneal infections, among others, have been reported. The high rate of intrinsic resistance to broad-spectrum antibiotics is a matter of concern since there are no standard guidelines for the management and treatment of this infection. Here, we present the case of a 94-year-old female who was admitted and intubated after a cerebral vascular accident. During her stay, she developed a fever. The deep tracheal aspirate culture was positive for gram-negative bacilli with smooth, circular, and yellow-pigmented colonies that were later identified as C. indologenes. Antimicrobial susceptibility tests done with VITEK 2 and by the Kirby-Bauer disc diffusion method showed susceptibility to ciprofloxacin, minocycline, and trimethoprim-sulfamethoxazole and resistance to all other tested antimicrobials. The infection was successfully treated with ciprofloxacin antibiotic. To the best of our knowledge, this is the first reported case of C. indologenes infection in Lebanon.
Insights
Chryseobacterium indologenes is a rare pathogen causing opportunistic infections. This case highlights successful treatment of Chryseobacterium indologenes pneumonia with ciprofloxacin in Lebanon.
Area of Science:
- Medical Microbiology
- Infectious Diseases
Background:
- Chryseobacterium indologenes is a rare, non-fermenting Gram-negative pathogen.
- Nosocomial infections caused by this bacterium are increasing, often linked to medical devices.
- High intrinsic antibiotic resistance poses treatment challenges.
Observation:
- A 94-year-old female patient intubated for a cerebral vascular accident developed a fever.
- Tracheal aspirate cultures identified Chryseobacterium indologenes, characterized by yellow-pigmented colonies.
- Antimicrobial susceptibility testing revealed resistance to most antibiotics but susceptibility to ciprofloxacin, minocycline, and trimethoprim-sulfamethoxazole.
Findings:
- The patient's Chryseobacterium indologenes infection was successfully treated with ciprofloxacin.
- This case represents the first reported instance of C. indologenes infection in Lebanon.
Implications:
- Ciprofloxacin is a viable treatment option for Chryseobacterium indologenes infections.
- This case underscores the importance of accurate identification and susceptibility testing for rare pathogens.
- Further research is needed to establish effective treatment protocols for C. indologenes infections.
Related Concept Videos
Pneumonia III: Complications and Assessment
Acute Respiratory Failure-III
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

